MarketCap
Minerva Neurosciences NERV
$ 2.42
5.22%
Facebook
X
Telegram
Minerva Neurosciences PEG Ratio | NERV
Annual PEG Ratio Minerva Neurosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.000059 | -0.00264 | 0.000442 | 0.000087 | 0.000024 | 0.671 | 0.1 | 0.0879 | -0.465 | -0.717 | -0.0607 | 0.000406 | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.671 | -0.717 | -0.0321 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Oncolytics Biotech
ONCY
|
0.201 | $ 0.44 | -2.01 % | $ 42.2 M |  Canada |
 |
Kamada Ltd.
KMDA
|
-0.244 | $ 7.22 | 5.09 % | $ 416 M |  Israel |
 |
Neurocrine Biosciences
NBIX
|
0.957 | $ 164.42 | 2.91 % | $ 16.4 B |  USA |
 |
Nanobiotix S.A.
NBTX
|
0.249 | $ 30.7 | 2.05 % | $ 1.47 T |  France |
 |
Mereo BioPharma Group plc
MREO
|
-0.000588 | $ 0.28 | 0.93 % | $ 223 M |  Britain |
 |
Maravai LifeSciences Holdings
MRVI
|
-0.0142 | $ 7.53 | 7.81 % | $ 1.09 B | USA |
 |
Lexicon Pharmaceuticals
LXRX
|
0.105 | $ 1.78 | 10.25 % | $ 646 M | USA |
 |
Moleculin Biotech
MBRX
|
-0.00013 | $ 8.87 | 1.6 % | $ 10.5 M | USA |
 |
Nurix Therapeutics
NRIX
|
-0.478 | $ 15.3 | 3.1 % | $ 1.33 B | USA |
 |
Nkarta
NKTX
|
0.126 | $ 1.75 | 11.15 % | $ 129 M | USA |
 |
MacroGenics
MGNX
|
311 | $ 2.35 | 5.86 % | $ 148 M | USA |
 |
Protagonist Therapeutics
PTGX
|
0.419 | $ 131.96 | -2.54 % | $ 8.39 B | USA |
 |
Novo Nordisk A/S
NVO
|
0.189 | $ 40.36 | 0.21 % | $ 179 B |  Danmark |
 |
Marker Therapeutics
MRKR
|
-0.0143 | $ 0.91 | 0.95 % | $ 13.9 M | USA |
 |
NextCure
NXTC
|
-0.00319 | $ 5.55 | 8.61 % | $ 15.8 M | USA |
 |
PMV Pharmaceuticals
PMVP
|
0.306 | $ 1.25 | -1.57 % | $ 65.7 M | USA |
 |
Olema Pharmaceuticals
OLMA
|
-0.477 | $ 7.32 | 8.21 % | $ 637 M | USA |
 |
Kymera Therapeutics
KYMR
|
2.16 | $ 132.5 | 3.42 % | $ 11.2 B | USA |
 |
Oragenics
OGEN
|
-0.00446 | $ 0.35 | 0.29 % | $ 755 K | USA |
 |
Ovid Therapeutics
OVID
|
0.2 | $ 2.86 | 10.66 % | $ 372 M | USA |
 |
Passage Bio
PASG
|
-0.0141 | $ 3.9 | 12.72 % | $ 12.5 M | USA |
 |
Vaxcyte
PCVX
|
-446 | $ 63.86 | 3.13 % | $ 8.69 B | USA |
 |
Relay Therapeutics
RLAY
|
-0.0681 | $ 18.59 | 9.32 % | $ 3.19 B | USA |
 |
Precigen
PGEN
|
0.0184 | $ 4.47 | 5.81 % | $ 1.4 B | USA |
 |
Avidity Biosciences
RNA
|
-0.617 | $ 8.36 | 0.48 % | $ 1.15 B | USA |
 |
Phio Pharmaceuticals Corp.
PHIO
|
-0.00444 | $ 0.8 | -1.38 % | $ 4.79 M | USA |
 |
Praxis Precision Medicines
PRAX
|
-0.07 | $ 277.94 | 5.85 % | $ 6.25 B | USA |
 |
Prelude Therapeutics Incorporated
PRLD
|
0.0997 | $ 3.59 | 0.98 % | $ 276 M | USA |
 |
ProQR Therapeutics N.V.
PRQR
|
0.312 | $ 1.36 | 1.88 % | $ 143 M |  Niderland |
 |
Ocular Therapeutix
OCUL
|
-0.782 | $ 6.61 | 2.8 % | $ 1.24 B | USA |
 |
PolyPid Ltd.
PYPD
|
-0.00443 | $ 6.08 | 7.23 % | $ 99.4 M | Israel |
 |
Outlook Therapeutics
OTLK
|
-0.00407 | $ 0.44 | -0.93 % | $ 15.3 M | USA |
 |
uniQure N.V.
QURE
|
0.0338 | $ 21.68 | 3.19 % | $ 1.25 B | Niderland |
 |
Ultragenyx Pharmaceutical
RARE
|
-0.947 | $ 15.48 | -0.58 % | $ 1.53 B | USA |
 |
Rafael Holdings
RFL
|
-0.0215 | $ 1.02 | -4.67 % | $ 52.4 M | USA |
 |
REGENXBIO
RGNX
|
0.0212 | $ 7.62 | 3.25 % | $ 393 M | USA |
 |
Rigel Pharmaceuticals
RIGL
|
0.00182 | $ 39.52 | -13.54 % | $ 711 M | USA |
 |
Celsion Corporation
CLSN
|
-0.000473 | - | -6.63 % | $ 13.9 M | USA |
 |
I-Mab
IMAB
|
0.0579 | - | - | $ 866 M |  China |
 |
Tenax Therapeutics
TENX
|
-0.00225 | $ 1.68 | 3.07 % | $ 65.9 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
-0.0281 | - | 2.54 % | $ 160 B | France |
 |
Scholar Rock Holding Corporation
SRRK
|
-2 | $ 46.77 | 2.78 % | $ 5.36 B | USA |
 |
CureVac N.V.
CVAC
|
4.05 | - | - | $ 867 M |  Germany |
 |
Spero Therapeutics
SPRO
|
-0.1 | $ 1.03 | 1.47 % | $ 57.7 M | USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
1.57 | - | 0.74 % | $ 768 M | Israel |